ArticleTurkish archives of pediatrics2025
Possible Predictors of Adverse Outcomes in Children with Acute Viral Hepatitis in a Low-Middle-Income Country.
Article in Turkish archives of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the causes, clinical presentations, and biochemical profiles of children with acute viral hepatitis (AVH) while identifying potential factors that may predict mortality in these cases. Materials and Methods: This study was conducted in the Bangabandhu Sheikh Mujib Medical University (currently Bangladesh Medical University) setting among 158 children between July 2022 and November 2024. Children (≤ 18 years) who exhibited symptoms of AVH were enrolled in the study. A comprehensive history, physical examination, and relevant investigations were documented. Patients were monitored until complete recovery, and the outcome was recorded. The data were analyzed using SPSS version 25 (IBM SPSS Corp.; Armonk, NY, USA). Results: Hepatitis A was the most common etiology (76.6%) of AVH. Other etiologies include hepatitis E (1.6%), hepatitis C (0.6%), non-A-E hepatitis (6.3%), dengue hepatitis (1.9%), hepatitis A virus (HAV) + hepatitis E virus (4.4%), HAV + dengue (0.6%), and HAV + Salmonella (8.2%). A total of 41.1% of patients developed atypical features with complications. The overall mortality rate was 6.3% (10 children). Splenomegaly, ascites, bleeding manifestations, hemolysis, pleural effusion, features of encephalopathy and acute liver failure, raised serum bilirubin, prolonged PT (prothrombin time) and INR (international normalization ratio), and low albumin showed a significant difference between survivor and non-survivor groups. Conclusion: Hepatitis A virus is the leading cause of AVH, and the overall prognosis is good. The mortality rate was notably higher among boys. Splenomegaly, ascites, bleeding manifestations, hemolysis, pleural effusion, features of encephalopathy and acute liver failure, raised serum bilirubin, prolonged PT and INR, and low albumin would serve as possible predictors of mortality in pediatric AVH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.